• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[普通内科病房收治的急性心肌梗死患者的溶栓治疗]

[Thrombolytic therapy in acute myocardial infarction hospitalized in a general internal medicine ward].

作者信息

Błasiak M, Zawadowicz B, Pacyk G

机构信息

Oddziału Chorób Wewnetrznych Wojewódzkiego Szpitala Zespolonego, Czestochowie.

出版信息

Pol Tyg Lek. 1993;48(14-15):316-7.

PMID:8415244
Abstract

Well known benefits of the thrombolytic therapy in early phases of the myocardial infarction justify such a treatment also in these hospitals in which cardiac catheterization or cardiosurgery are inaccessible. The authors discuss their two-year experience with treating patients with myocardial infarction in such conditions.

摘要

溶栓疗法在心肌梗死早期阶段的显著益处,使得在那些无法进行心脏导管插入术或心脏手术的医院中也有必要采用这种治疗方法。作者讨论了他们在这种情况下治疗心肌梗死患者的两年经验。

相似文献

1
[Thrombolytic therapy in acute myocardial infarction hospitalized in a general internal medicine ward].[普通内科病房收治的急性心肌梗死患者的溶栓治疗]
Pol Tyg Lek. 1993;48(14-15):316-7.
2
[Thrombolytic therapy for acute myocardial infarction in the general internal medicine ward].[普通内科病房急性心肌梗死的溶栓治疗]
Pol Tyg Lek. 1996 Mar;51(10-13):150-2.
3
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).新型抗凝剂Vasoflux与肝素作为链激酶辅助治疗急性心肌梗死的随机对照研究:VITAL研究(Vasoflux急性心肌梗死溶栓国际试验)结果
Am Heart J. 2001 Aug;142(2):237-43. doi: 10.1067/mhj.2001.116759.
4
An audit of thrombolytic therapy in a rural hospital.
Aust Fam Physician. 1993 Oct;22(10):1866-8.
5
Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.在发病7至12小时就诊的急性心肌梗死患者中,大剂量肝素和链激酶在出院时产生相似的心肌梗死溶栓治疗(TIMI)3级血流。
Indian Heart J. 2000 Mar-Apr;52(2):183-6.
6
[Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].[血清肌红蛋白浓度作为急性心肌梗死患者溶栓治疗后再灌注的早期标志物]
Pol Merkur Lekarski. 1997 Sep;3(15):109-12.
7
Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.肝素作为急性心肌梗死溶栓治疗的辅助药物。
Biomed Pharmacother. 1996;50(6-7):243-53. doi: 10.1016/0753-3322(96)84821-9.
8
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction.肝素可改变接受急性心肌梗死溶栓治疗患者的血小板计数及功能。
Thromb Haemost. 1993 May 3;69(5):522-3.
9
Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.激肽系统抑制剂作为预防或减少急性心肌梗死患者溶栓治疗中再灌注损伤的替代方法。
Georgian Med News. 2006 Nov(140):54-62.
10
[Comparison of short and protracted streptokinase therapy in acute myocardial infarction].[急性心肌梗死中短期与延长链激酶治疗的比较]
Z Gesamte Inn Med. 1975 Sep 15;30(18):186-9.